Effect of clarithromycin and azithromycin on production of cytokines by human monocytes

被引:132
作者
Khan, AA
Slifer, TR
Araujo, FG
Remington, JS
机构
[1] Palo Alto Med Fdn, Res Inst, Dept Immunol & Infect Dis, Palo Alto, CA 94301 USA
[2] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
关键词
macrolide; clarithromycin; azithromycin; cytokine; monocyte; immunomodulation;
D O I
10.1016/S0924-8579(98)00091-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We examined the in vitro effect of clarithromycin and azithromycin on cytokine production by LPS and Pansorbin stimulated human monocytes. At concentrations that are physiologically achievable, both antibiotics affected in vitro production of IL-alpha, IL-1 beta, IL-6, IL-10, GM-CSF and TNF-alpha to varying degrees. Of those individuals in whom a significant increase or decrease in cytokine production was noted, clarithromycin treatment resulted in a significant suppression of production of each cytokine in 71% and a significant increase in 29% of the individuals. Similar results were noted with azithromycin. The results with IL-6 and TNF-alpha in the clarithromycin studies were most striking. A significant decrease was noted in 60% of individuals for IL-6 and 86% for TNF-alpha. For azithromycin, the most interesting results were for IL-alpha (decrease in 100% of individuals) and for TNF-alpha (decrease in 100% of individuals). These results show that both clarithromycin and azithromycin alter cytokine production in human monocytes and thus possess immunomodulatory activity. (C) 1999 Published by Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:121 / 132
页数:12
相关论文
共 41 条
[1]   AZITHROMYCIN, A MACROLIDE ANTIBIOTIC WITH POTENT ACTIVITY AGAINST TOXOPLASMA-GONDII [J].
ARAUJO, FG ;
GUPTILL, DR ;
REMINGTON, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :755-757
[2]   SYNERGISTIC COMBINATION OF AZITHROMYCIN AND SULFADIAZINE FOR TREATMENT OF TOXOPLASMOSIS IN MICE [J].
ARAUJO, FG ;
LIN, T ;
REMINGTON, JS .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (01) :71-73
[3]   ACTIVITY OF CLARITHROMYCIN ALONE OR IN COMBINATION WITH OTHER DRUGS FOR TREATMENT OF MURINE TOXOPLASMOSIS [J].
ARAUJO, FG ;
PROKOCIMER, P ;
LIN, T ;
REMINGTON, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (11) :2454-2457
[4]  
BRAUMANN H, 1994, IMMUNOL TODAY, V15, P74
[5]  
Bryskier A.J., 1993, Macrolides: chemistry, pharmacology and clinical uses
[6]   Effect of grapefruit juice on clarithromycin pharmacokinetics [J].
Cheng, KL ;
Nafziger, AN ;
Peloquin, CA ;
Amsden, GW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :927-929
[7]  
CHIN J, 1993, J IMMUNOL, V151, P5574
[8]   THE PHARMACOKINETICS AND INFLAMMATORY FLUID PENETRATION OF ORALLY-ADMINISTERED AZITHROMYCIN [J].
COOPER, MA ;
NYE, K ;
ANDREWS, JM ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (04) :533-538
[9]  
DE WMR, 1991, J EXP MED, V174, P1209
[10]   THE PHARMACOKINETICS OF AZITHROMYCIN IN HUMAN SERUM AND TISSUES [J].
FOULDS, G ;
SHEPARD, RM ;
JOHNSON, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :73-82